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Parathyroid sensing of the direction of change of calcium in uremia. It
could be advantageous for the parathyroids to be able to sense not only
the absolute concentration of extracellular Ca2, but also the rate and
direction of change of Ca2, thereby allowing the parathyroids to
respond earlier to threats to Ca2 homeostasis. By using high and low
Ca2 dialysis in a single session, we examined the parathyroid response
to direction of change of Ca2 during acute Ca2 perturbation in nine
hemodialysis patients. Separate PTH/ionized calcium (PTH/iCa) re-
sponse curves were generated for rising Ca2 and falling Ca2. Signif-
icant directional hysteresis (higher PTH level during falling than during
rising Ca2) was found. During hypercalcemia, PTH levels were
between 2.2 and 1.6 times higher at iCa concentrations of between 0 and
+0.1 m above the baseline iCa, when Ca2 was falling than when it
was rising. During the phase of induced hypocalcemia, parathyroid
fatigue was seen in six of the nine patients. Fatigue patients tended to
have higher basal PTH (1-84) levels than those not showing fatigue. The
existence of fatigue provides an explanation for directional hysteresis
during hypocalcemia, and therefore parathyroid sensing of the direction
of change of Ca2 could not be assessed during hypocalcemia. These
studies demonstrate a capacity of the parathyroids to sense the direc-
tion of movement of Ca2 during hypercalcemia.
The principal physiological regulators of parathyroid hor-
mone (PTH) secretion are extracellular calcium (Ca2) concen-
tration [1, 2] and plasma calcitriol [l,25(OH)2D3] level [3, 4]. A
sigmoidal relationship between PTH secretion and Ca2 has
been found both in vitro [5—8] and in viva [9—111, such that even
slight perturbation of the ambient extracellular ionized calcium
(iCa) concentration induces a large reciprocal change in the
PTH level within seconds [12]. This sigmoidal response has also
been documented in dialysis patients with hyperparathyroidism
[13—15] and in uremic patients receiving calcitriol therapy [16,
17]. In a recent study of hemodialysis patients, we have also
found that calcitriol modified this PTH/iCa relationship in a
manner suggestive of a reduction in the operating range but not
the sensitivity of the parathyroids to Ca21 [18].
Studies by others and ourselves have suggested that PTH
release may be determined not only by the absolute Ca2
concentration but also by the direction and the rate of change of
Ca2 [11, 19—21]. Physiologically, such an anticipatory capacity
Received for publication August 26, 1992
and in revised form October 19, 1992
Accepted for publication October 19, 1992
© 1993 by the International Society of Nephrology
would be advantageous by enabling the parathyroids to recog-
nize and respond more rapidly to threats to Ca2 homeostasis.
An hysteretic relationship between PTH and Ca2, in which
at a given blood Ca2 concentration a higher level of PTH exists
during induction of hypocalcemia than during recovery from
hypocalcemia, and also during the recovery from induced
hypercalcemia than during the induction of hypercalcemia, was
first described in normal humans by Conlin et a! [221. Using an
intact molecule (PTH, 1-84) assay these authors measured PTH
levels during separate calcium and citrate infusions which gave
rise to a perturbation of iCa concentration to 0.15 m above
and below the baseline iCa. More recently, Felsenfeld et a!
when examining the PTH (1-84) response to induced hypocal-
cemia and hypercalcemia by separate hypocalcemic and hyper-
calcemic dialyses also documented similar hysteretic findings in
hemodialysis patients with low turnover aluminum bone disease
[15].
However, because our own preliminary findings [18] indi-
cated that during acute hypocalcemia many uremic patients
exhibited parathyroid fatigue, whereby increased PTH release
is not sustained during progressive hypocalcemia, the possibil-
ity exists that the previously described hysteretic relationship
between PTH and Ca2 may reflect no more than exhaustion of
PTH stores within the parathyroid cells. The present study was
designed to examine the hysteresis resulting from fatigue, and
to distinguish it from a specific capacity of the parathyroid cells
to sense the direction of change of Ca2.
Methods
Patients
Nine (6 males, 3 females) adult stable hemodialysis patients
with varying degrees of hyperparathyroidism were studied.
Their age ranged from 24 to 70 (median 55) years and they had
been on hemodialysis from two to 60 (median 24) months. The
renal diagnoses included: three adult polycystic kidney disease,
two chronic glomerulonephritis, two unknown, one bilateral
nephrectomy for renal cell cancer and one chronic pyelonephri-
tis. At the time of the study, no patient had received vitamin D
analogues for at least three months previously and none had
undergone parathyroidectomy. All the patients were dialyzed
on Nephross hollow-fiber dialyzers (Organon Teknika) and
used standard dialysate buffered by acetate with a dialysate
flow rate of 500 ml/min and blood flow rate of 3 ml/kg body
wt/min. The response of the PTH/iCa relationship to pulse oral
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Table 1. Clinical details of patients
Basal
Patient
no.
Age
years Sex
Duration of
dialysis
months
ionized
calcium
Serum
phosphate PTH
pg/mi
Serum alkaline
phosphatasea
U/liter
Serum
aluminium
pg/litermmoi/liter
1 38 M 6 1.15 1.56 18 49 25
2 55 M 34 1.28 2.07 62 112 30
3 70 M 60 1.20 2.43 86 165 80
4 44 M 24 1.06 0.97 129 338 25
5 51 M 5 1.15 2.02 269 71 70
6 56 F 70 1.03 1.26 269 110 30
7 57 M 109 1.12 2.29 338 181 45
8 24 F 2 1.07 1.65 820 119 9
9 55 F 16 1.12 1.23 924 124 5
ALP (normal range 30 to 120 U/liter)
calcitriol in six of the patients was the subject of a previous
report [18].
Protocols
PTH/iCa curves were generated by sequentially dialyzing
patients against a dialysate with a Ca2 concentration of 2.5
mM, followed immediately by a period of Ca2-free dialysis.
This was then followed by a further period of dialysis against
Ca2 concentration of 2.5 m until the baseline iCa concentra-
tion was reached again. This cycle of high, low, and high Ca2
dialysis aimed during a single dialysis session to raise, and then
depress, the whole blood iCa by 0.25 msi above and below
baseline, followed by a return to the baseline iCa. The proce-
dure perturbed the patients' iCa in a predictable manner that
showed good reproducibility on repeated studies. Throughout
the procedure, blood samples for iCa and PTH measurement
were taken at five minute intervals.
Assays
Intact parathyroid hormone (1-84) was measured by an im-
muno-radiometric assay (Allegro, Nichols Institute, San Juan
Capistrano, California, USA). The normal range for this assay
in our laboratory is 10 to 65 pg/mI, with a within-run CV of <7%
and a between-run CV of <5% in the range 10 to 1000 pg/mi. All
samples for PTH estimation from the same patient were mea-
sured in the same assay run. Ionized calcium was measured in
fresh whole blood using a Kone "Microlyte" ion selective
analyzer (Kone Instruments, Warrington, UK). The mean SD
concentration of iCa in 50 normal subjects was 1.22 0.06 mM.
Serum total calcium (adjusted to 46 g/liter of albumin) [23],
albumin, phosphate and alkaline phosphatase were measured
by standard procedures using a Technicon SMAC III Analyser
(Technicon, Basingstoke, UK). Serum aluminum was measured
by flameless atomic absorption spectrophotometry [24].
Data analysis
Data are expressed as mean SE. The paired PTH and iCa
values obtained were used to plot the PTH/iCa response curves,
generated separately for each direction of movement of calcium
in the individual patients. The PTH data were transformed
semi-logarithmically to improve the linearity of the relation-
ships and allow comparison as previously described [18]. Re-
gression analyses of the semi-log plots were performed by the
method of least squares. Data comparison was carried out by
Student's paired t-test, with a P value of <0.05 being regarded
as significant.
Results
The clinical details of the patients are shown in Table 1. The
severity of hyperparathyroidism as judged by the basal PTH
concentrations in these patients varied widely (18 to 820 pg/mi)
with a mean of 324 pg!ml. Mean (range) serum alkaline phos-
phatase (NR 30 to 100) was 142 (49 to 338) U/liter. Serum
aluminium was 35 (5 to 80) p.g/liter with only two patients
having levels elevated above 50 gIliter. Radiological evidence
of hyperparathyroid bone disease was seen in three patients
(Nos. 4, 7 and 9) in whom serum alkaline phosphatase was also
elevated.
The PTHIiCa curves from three different sections of the
calcium perturbation protocol: (a) rising Ca2 from baseline, (b)
falling Ca2, and (c) rising Ca2 towards baseline of the nine
patients showed considerable heterogeneity despite the use of
identical study protocols (Fig. 1).
The mean (SE, range) durations required to increase iCa from
basal level by 0.25 m, to reduce from peak hypercalcemia to
0.25 m below the basal iCa level and to increase iCa from the
nadir of hypocalcemia back to basal level again were 71 (8,
range 30 to 115) minutes, 98 (10, 55 to 155) minutes and 34(5, 15
to 65) minutes, respectively.
Directional hysteresis was evident in seven out of nine
patients (Patients 1 through 3, 6 through 9), and particularly so
in the hypocalcemic region. However, in six patients (Patients
2, 5 through 9), an additional component of "parathyroid
fatigue" was seen during the phase of induced hypocalcemia.
The likelihood of showing parathyroid fatigue appeared to
relate to the basal PTH level; with one exception (Patient 2), all
the patients who showed parathyroid fatigue had basal PTH
levels between four and 15 times the upper limit of normal
(mean 447 pglml). The three "non-fatigue" patients had normal
(patient 1, 18 pg/ml) or only moderately raised PTH levels
(patients 3, 86 pg/mi and 4, 129 pg/mi, respectively).
The presence of hysteresis in this region of induced hypocal-
cemia cannot therefore be ascribed with certainty to directional
sensing of Ca2 by the parathyroid cells. Further analysis of
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parathyroid sensing of the direction of change in Ca2 concen-
tration was therefore confined to the region of induced hyper-
calcemia in which the period of rising Ca2 preceded that of
falling Ca2, thereby excluding fatigue as a possible confound-
ing factor.
Data from the hypercalcemic region were used to generate
the linear regression equations of the 18 logPTH/iCa plots.
Their corresponding coefficients of correlation, r, and P-values
are shown in Table 2. This indicated that the mean slope of the
regression lines during rising Ca2 was significantly different
from that of the falling Ca2 (—5.3 0.7 vs. —8,3 1.0,
respectively, P < 0.03), demonstrating that the parathyroid
response to increment or decrement of Ca2 was greater when
the extracellular Ca2 concentration was recovering from the
peak of induced hypercalcemia (falling Ca2) than it was during
the induction (rising Ca2). A composite plot of logPTH
against the change of iCa (iCa) in the nine patients was
constructed by pooling the data obtained using the regression
equations to calculate logPTH values at different values of
iCa (between 0 and +0.25 mM) for the individual patients (Fig.
2). This showed upward and rightward shift of the line repre-
senting the composite slope of falling Ca2 in relation to that
representing rising Ca21. The intercepts of the two composite
lines in abscissae drawn at ziCa of 0, +0.05, and +0.1 m were
significantly different (P < 0.004, P < 0.006, P < 0.02, respec-
tively), indicating that at these concentrations of iCa, serum
PTH was significantly greater when iCa was falling than when it
was rising. The respective ratios of PTH at these iCa concen-
trations were: 2.2 at 0 mrsi, 1.9 at +0.05 msi and 1.6 at +0.1 mM.
Across the hypercalcemic region (baseline iCa + 0.25 mM),
the mean operating range (defined by the regression equations)
of the parathyroids was significantly greater when Ca2 was
falling than when it was rising (521 61 pg/mI vs. 215 26
pg/mi, P < 0.043; Fig. 3).
Discussion
The regulation of PTH secretion is tightly linked to Ca2
sensing by the parathyroid cells [25]. There is now an increasing
body of evidence to support the concept that extracellular
Ca2, as well as other di- and trivalent cations (such as Mg2
and Ba2), modulates parathyroid function by a cell membrane
receptor-like mechanism [26], with the cations being the pri-
mary messengers, which are coupled to intracellular effector
systems by one or more guanine nucleotide regulatory proteins
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Fig. 1. Individual PTH/iCa plots of the nine
patients. Symbols are: (0) rising calcium from
baseline; (•) falling calcium from peak
hypercalcemia to the nadir of hypocalcemia;
(Lx) rising calcium from the nadir of
hypocalcemia back to baseline.
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Table 2. Linear regression equations of rising Ca2 versus falling Ca2
Patient Rising Ca2 Falling Ca2
r Pno. r P
1 y = 2.6—3.3x 0.548 0.0424 y = 3.8—l1.8x 0.963 0.0005
2 y = 3.9—5.lx 0.864 0.0001 y = 4.8—3.2x 0.959 0.0002
3 y = 4.2—2. lx 0.735 0.0100 y = 5.1—6.3x 0.958 0.0026
4 y = 5.0—5.5x 0.914 0.0040 y = 5.2—8.9x 0.965 0.0077
5 y = 5.3—6.Ox 0.894 0.0001 y = 5.7—7.6x 0.914 0.0161
6 y = 5.4—3,9x 0.869 0.0001 y = 7.4—1l.4x 0.951 0.0001
7 y = 5.7—8,4x 0.976 0.0001 y = 6.2—12.3x 0.929 0.0073
8 y = 6.5—5.4x 0.915 0.0001 y = 7.4—5.8x 0.953 0.0123
9 y = 6.7—8.Ox 0.862 0.0010 y = 6.8—7.9x 0.890 0.0013
Slopes: rising Ca2 vs. falling Ca2 (mean SE); —5.3(0.7) vs. —8.4(1.0), P < 0.03.
Intercepts (at x = 0): rising Ca2 vs. falling Ca2 (mean SE); 5.0 (0,4) vs. 5.8 (0.4), P < 0.004.
y = LogPTH (pg/ml); x = iCa (mmol/liter).
Rising iCa, Falling iCa,
baseline iCa to ÷ 0.25 mM # 0.25 m to baseline iCa
Fig. 3. Mean SE PTH operating ranges of the parathyroid during
rising and falling iCa in the hypercalcemic region (baseline iCa + 0.25
mM). P < 0.043.
(G proteins) [27, 28], which are in turn linked to intracellular
second messenger signaling systems including phosphoinositi-
des [29, 30], cAMP [31] and intracellular Ca2 concentration
[32, 33]. Recent studies have also suggested that this putative
cation-receptor may have a molecular mass of 500,000 kD, with
potentials for multiple metal binding sites [34], and exhibit
properties suggestive of positive cooperativity on binding on
Ca2 [25].
Teleologically, it could be advantageous for the parathyroids
to be able to sense the direction of change of Ca2 as well as the
absolute Ca2 concentration when defending against threats to
Ca homeostasis. In this study we demonstrated that, in the
region of hypercalcemia, the sensitivity of the parathyroids to
changes in Ca2 (reflected by the slope of the PTH/iCa rela-
tionship) is greater and the operating range of the parathyroids
(reflected by the intercepts of the PTH/iCa relationship at
various abscissae in the region of hypercalcemia, Fig. 3) is set
higher when Ca2 is falling than when it is rising. This hyster-
etic phenomenon is unlikely to be an artifact caused by a lag
between alterations in the glandular secretory activity and
changes in the circulating levels of PTH as this would be
expected to produce the opposite effect with PTH levels tending
to be lower for a given level of Ca2 during recovery from peak
hypercalcemia. Furthermore, it is also unlikely that rate-depen-
dent control of PTH levels during the induction and the accel-
erated recovery of hypercalcemia can explain this finding as in
previous in vivo studies rate-dependence of the control of PTH
secretion was not seen during hypercalcemia [20—22]. Nor is it
likely that variability of changes of other cations and anions
during dialysis is a confounding factor—such variability is likely
to have been small, and its impact on PTH secretion slight or
non-existent. The observations in this study therefore suggest
that the parathyroids are able to sense the direction of change of
Ca2, at least in the region of hypercalcemia.
The exact mechanism for this hysteresis is unclear. It could
be explicable on the basis of the different levels of cooperativity
caused by ligand-receptor binding as a result of different direc-
tional Ca2 movements. Another explanation could be related
to the changes in the extracellular Ca2-dependent intracellular
degradation of PTH [35]. When the extracellular Ca2 concen-
tration is reduced, a greater proportion of the newly synthe-
sized PTH escapes breakdown and is available for secretion.
However, change in the rate of degradation of PTH in response
to alterations in the extracellular Ca2 concentration has been
estimated to require at least 40 minutes [35]. This mechanism is
therefore unlikely to play a significant role in the genesis of the
directional hysteresis seen in the hypercalcemic region in which
rapid PTH response to Ca2 was seen within minutes of the
change in the direction of Ca2 movement (Fig. 1).
It is evident from the present study that when parathyroid
0 0.05 0.10 0.15 0.20 0.25
8.0 3000
7.0 1100
6.0 400
5.0 1500
4.0 550
—j 3.0 20
2.0 7.4
z.iCa, mmol/lifer
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secretory capacity was assessed in this manner, marked para-
thyroid fatigue occurred during induced hypocalcemia in some
patients. In the study by Felsenfeld et a! [15], parathyroid
fatigue was not described. This perhaps was because of patient
selection, in that their patients were patients with low turnover
aluminum bone disease who had relatively low basal and
maximal PTH levels (132 37 and 389 91 pg/mI vs. 447 140
and 1080 311 pg/ml as found in our 6 "fatigue" patients).
Lower PTH levels, comparable with those studied by Felsen-
feld et a! [15], were found in our three patients showing "no
fatigue" during the study (78 32 and 371 159 pg/mi for basal
and maximal PTH levels, respectively). That fatigue appeared
to affect patients with more severe hyperparathyroidism could
be explained on the basis of a more rapid depletion of intracel-
lular PTH stores stimulated by hypocalcemia, on a background
of rapid PTH release to maintain the high basal P1'H level. A
preliminary report of studies in normal subjects and patients
with primary hyperparathyroidism using tn-sodium citrate in-
fusion clamp technique to induce sustained and steady hypocal-
cemia of 0.2 m below the baseline iCa has demonstrated a
similar fatigue phenomenon, PTH (1-84) peaked within five to
10 minutes at a level four to six times the baseline concentra-
tion, but then declined to a steady state of only two to three
times the baseline level [36].
Because it takes about 30 minutes for newly synthesized PTH
to become available for secretion [35], the early secretory
response of the parathyroid cells to hypocalcemia must involve
the release of pre-formed hormone. In bovine species, such
hormonal stores are thought to be sufficient to maintain maxi-
mal hypocalcemic stimulated rate of PTH secretion for about 1
to 1.5 hours [9]. It is also known that the changes in the level of
pre-pro-PTH mRNA in response to alterations in extracellular
calcium require  three hours in rats [37] and  12 hours in
cows [38]. Such responses are therefore too slow to provide
increased amounts of newly synthesized hormone for release
within minutes of the onset of persistent hypocalcemia. On the
basis of these findings, and despite the fact that a greater
proportion of the newly synthesized PTH escapes breakdown
when the extracellular Ca2" concentration is reduced [35], it is
not surprising that parathyroid fatigue was seen in our patients
who were subjected to progressive and prolonged hypocalce-
mia.
In our analysis of the PTH/iCa response, we have not defined
"set point" in our PTH/iCa plots, partly because the physio-
logical relevance of set point, maximal PTH, minimal PTH and
slope to set point, as previously defined in in vitro systems [7]
is less certain in in vivo. This is borne out in the present study
in which the development of parathyroid fatigue presents both
conceptual and analytical problems in that the physiological
significance of the point at which fatigue develops is uncertain,
and subsequent curve fitting and definition of those curve-
derived indices dependent on the fatigue point may be flawed.
In conclusion, we have demonstrated directional hysteresis
of the parathyroid response to Ca2 in uremic patients with
varying degrees of hyperparathyroidism. Only parathyroid
sensing of the direction of change of Ca2 can adequately
explain the observed hysteresis during hypercalcemia. In con-
trast, during hypocalcemic perturbation parathyroid fatigue
may confound the interpretation of hysteresis, especially in
patients with severe or moderately severe hyperparathyroid-
ism. These findings have demonstrated the existence of an
additional teleologically plausible component to the regulation
of PTH secretion by extracellular Ca2.
Reprint requests to Dr. John Cunningham, Department of Nephrol-
ogy, The Royal London Hospital, Whitechapel, London El IBB,
England, United Kingdom.
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